
AURN001 Achieves Dose-Dependent Response at 6 Months, With Zaina Al-Mohtaseb, MD
Individuals with corneal edema achieved a dose-dependent response at 6 months in best-corrected visual acuity (BCVA) with a single dose of varied concentrations of human corneal endothelial cell (CEC) therapy in combination with Y-27632 Rho-Kinase …